Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.

PloS one - 1 Jan 2013

Matito Almudena, Morgado José Mario, Álvarez-Twose Iván, Sánchez-Muñoz Laura, Pedreira Carlos Eduardo, Jara-Acevedo María, Teodosio Cristina, Sánchez-López Paula, Fernández-Núñez Elisa, Moreno-Borque Ricardo, García-Montero Andrés, Orfao Alberto, Escribano Luis

Abstract excerpt

BACKGROUND: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease behaviour and outcome. METHODS: In total 74 adult I...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Trees
Share to Demography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Mast Cells

Share to Mastocytosis, Systemic

Share to Multivariate Analysis

Share to Proto-Oncogene Proteins c-kit

Share to Tryptases

Source

Open in PubMed Open full text

Identifiers

PMID: 24155887
DOI: 10.1371/journal.pone.0076116
PMCID: PMC3796517

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24155887-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.PMID 24155887Read ↗

Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Diagnosis, progression patterns and prognostication in mastocytosis.Semantic proximity Read ↗

Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.Semantic proximity Read ↗

Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosisSemantic proximity Read ↗

Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management.Semantic proximity Read ↗

Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.Semantic proximity Read ↗

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.Semantic proximity Read ↗

How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).Semantic proximity Read ↗

Comprehensive Mastocytosis Data Analysis From A Single CenterSemantic proximity Read ↗

Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.